Research Press Releases

A new study, believed to be the world’s largest real-world study investigating the potential role of probiotics in perimenopause symptom management, has reported significant and clinically meaningf...

A new in vitro study has explored the potential of targeting the gut microbiome in people with decompensated advanced chronic liver disease (dACLD), finding that the multi-strain liquid probiotic S...

A laboratory study has investigated whether the multi-strain liquid probiotic Symprove could inhibit growth of harmful gut bacteria. Published in International Journal of Pharmaceutics, the study w...

A new study published in Food Research International is contributing to increasing scientific interest in how probiotics may influence gut microbiome disruption caused by antibiotics and gastrointe...

A pilot study has explored whether daily supplementation with the multi-strain liquid probiotic Symprove could help reduce gastrointestinal symptoms in marathon runners during training. Gastrointes...

A laboratory study has shown the multi-strain liquid probiotic Symprove to be effective in inhibiting the growth of harmful bacteria associated with diarrhoea. Bacterial pathogens are a leading cau...

New evidence presented at the 3rd Long COVID International Conference 2025 suggests that taking Symprove, the liquid multi-strain live and active bacteria food supplement, may support cognitive fun...

A new study published in Movement Disorders is adding to growing scientific interest in the relationship between the gut microbiome and neurological conditions such as Parkinson’s disease. The rese...

A new clinical trial has explored the potential of the multi-strain liquid probiotic Symprove to help manage irritable bowel syndrome (IBS) symptoms in people with inflammatory bowel disease (IBD) ...